By Miriam Raftery
Photo via U.S. Health and Human Services
December 19, 2020 (Washington D.C.) -- On Friday, the U.S. Food and Drug Administration announced that it has issued an Emergency Use Authorization for Moderna’s COVID-19 vaccine. This is the second vaccine to win approval, after the approval of a Pfizer vaccine earlier this month.
According to an announcement from the U.S. Health and Human Services agency, more than 5.9 million doses of the vaccine are allocated for jurisdictions to receive in the coming week.